In vitro assembly of virus-like particles of a gammaretrovirus, the murine leukemia virus XMRV

Journal of Virology

Volumn 86, Issue 3, 2012, Pages 1297-1306

  Hadravová, Romana ^a   de Marco, Alex ^b   Ulbrich, Pavel ^c   Štokrová, Jitka ^a   Doležal, Michal ^a,c   Pichová, Iva ^a   Ruml, Tomáš ^c   Briggs, John A G ^b   Rumlová, Michaela ^a  

^a INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^c INSTITUTE OF CHEMICAL TECHNOLOGY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; GAG PROTEIN; MATRIX PROTEIN; NUCLEOCAPSID PROTEIN; PROLINE; STRUCTURAL PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CRYOELECTRON MICROSCOPY; DENSITY; DNA HAIRPIN; ELECTRON MICROSCOPY; GENE DELETION; IN VITRO STUDY; MURINE LEUKEMIA VIRUS; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; RETROVIRUS; STRUCTURE ANALYSIS; VIRUS ASSEMBLY; VIRUS LIKE AGENT; XENOTROPIC MULV RELATED VIRUS;

AMINO ACID SEQUENCE; BASE SEQUENCE; CRYOELECTRON MICROSCOPY; DNA PRIMERS; ESCHERICHIA COLI; FOURIER ANALYSIS; LEUKEMIA VIRUS, MURINE; MICROSCOPY, ELECTRON, TRANSMISSION; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; PROTEOLYSIS; SEQUENCE HOMOLOGY, AMINO ACID; VIRAL PROTEINS; VIRION; VIRUS ASSEMBLY;

GAMMARETROVIRUS; MIRIDAE; MURINE LEUKEMIA VIRUS; XENOTROPIC MURINE LEUKEMIA VIRUS;

EID: 84857098150     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05564-11     Document Type: Article

References (68)

1. Accola MA, Hoglund S, Gottlinger HG. 1998. A putative alpha-helical structure which overlaps the capsid-p2 boundary in the human immunodeficiency virus type 1 Gag precursor is crucial for viral particle assembly. J. Virol. 72:2072-2078.
2. Accola MA, Strack B, Gottlinger HG. 2000. Efficient particle production by minimal gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain. J. Virol. 74:5395-5402.
3. Bohmova K, et al. 2010. Effect of dimerizing domains and basic residues on in vitro and in vivo assembly of Mason-Pfizer monkey virus and human immunodeficiency virus. J. Virol. 84:1977-1988.
4. Borsetti A, Ohagen A, Gottlinger HG. 1998. The C-terminal half of the human immunodeficiency virus type 1 Gag precursor is sufficient for efficient particle assembly. J. Virol. 72:9313-9317.
5. Briggs JA, Johnson MC, Simon MN, Fuller SD, Vogt VM. 2006. Cryoelectron microscopy reveals conserved and divergent features of gag packing in immature particles of Rous sarcoma virus and human immunodeficiency virus. J. Mol. Biol. 355:157-168.
6. Briggs JA, et al. 2009. Structure and assembly of immature HIV. Proc. Natl. Acad. Sci. U. S. A. 106:11090-11095.
7. Briggs JA, et al. 2004. The stoichiometry of Gag protein in HIV-1. Nat. Struct. Mol. Biol. 11:672-675.
8. Campbell S, Vogt VM. 1995. Self-assembly in vitro of purified Ca-Nc proteins from Rous sarcoma virus and human immunodeficiency virus type 1. J. Virol. 69:6487- 6497.
9. Cheslock SR, et al. 2003. Charged assembly helix motif in murine leukemia virus capsid: an important region for virus assembly and particle size determination. J. Virol. 77:7058-7066.
10. Cornilescu CC, Bouamr F, Yao X, Carter C, Tjandra N. 2001. Structural analysis of the N-terminal domain of the human T-cell leukemia virus capsid protein. J. Mol. Biol. 306:783-797.
11. Datta SA, et al. 2011. Solution properties of murine leukemia virus Gag protein: differences from HIV-1 Gag. J. Virol. 85:12733-12741.
12. de Marco A, et al. 2010. Conserved and variable features of Gag structure and arrangement in immature retrovirus particles. J. Virol. 84: 11729-11736.
13. de Marco A, et al. 2010. Structural analysis of HIV-1 maturation using cryo-electron tomography. PLoS Pathog. 6:e1001215.
14. Ehrlich LS, Agresta BE, Carter CA. 1992. Assembly of recombinant human immunodeficiency virus type 1 capsid protein in vitro. J. Virol. 66:4874-4883.
15. Erlwein O, et al. 2011. Investigation into the presence of and serological response to XMRV in CFS patients. PLoS One 6:e17592.
16. Fischer N, et al. 2008. Prevalence of human gammaretrovirus XMRV in sporadic prostate cancer. J. Clin. Virol. 43:277-283.
17. Furuta RA, et al. 2011. No association of xenotropic murine leukemia virus-related virus with prostate cancer or chronic fatigue syndrome in Japan. Retrovirology 8:20.
18. Ganser BK, Li S, Klishko VY, Finch JT, Sundquist WI. 1999. Assembly and analysis of conical models for the HIV-1 core. Science 283:80-83.
19. Ganser-Pornillos BK, Yeager M, Sundquist WI. 2008. The structural biology of HIV assembly. Curr. Opin. Struct. Biol. 18:203-217.
20. Gitti RK, et al. 1996. Structure of the amino-terminal core domain of the HIV-1 capsid protein. Science 273:231-235.
21. Gross I, Hohenberg H, Huckhagel C, Krausslich HG. 1998. N-terminal extension of human immunodeficiency virus capsid protein converts the in vitro assembly phenotype from tubular to spherical particles. J. Virol. 72:4798-4810.
22. Gross I, Hohenberg H, Krausslich HG. 1997. In vitro assembly properties of purified bacterially expressed capsid proteins of human immunodeficiency virus. Eur. J. Biochem. 249:592-600.
23. Gross I, et al. 2000. A conformational switch controlling HIV-1 morphogenesis. EMBO J. 19:103-113.
24. Hilditch L, et al. 2011. Ordered assembly of murine leukemia virus capsid protein on lipid nanotubes directs specific binding by the restriction factor, Fv1. Proc. Natl. Acad. Sci. U. S. A. 108:5771-5776.
25. Hohn O, et al. 2009. Lack of evidence for xenotropic murine leukemia virus-related virus(XMRV) in German prostate cancer patients. Retrovirology 6:92.
26. Hong P, Li J, Li Y. 2010. Failure to detect xenotropic murine leukaemia virus-related virus in Chinese patients with chronic fatigue syndrome. Virol. J. 7:224.
27. Johnson MC, Scobie HM, Vogt VM. 2001. PR domain of rous sarcoma virus Gag causes an assembly/budding defect in insect cells. J. Virol. 75: 4407-4412.
28. Keller PW, Johnson MC, Vogt VM. 2008. Mutations in the spacer peptide and adjoining sequences in Rous sarcoma virus Gag lead to tubular budding. J. Virol. 82:6788-6797.
29. Khorasanizadeh S, Campos-Olivas R, Summers MF. 1999. Solution structure of the capsid protein from the human T-cell leukemia virus type-I. J. Mol. Biol. 291:491-505.
30. Kingston RL, et al. 2000. Structure and self-association of the Rous sarcoma virus capsid protein. Structure 8:617- 628.
31. Klikova M, Rhee SS, Hunter E, Ruml T. 1995. Efficient in-vivo and in-vitro assembly of retroviral capsids from Gag precursor proteins expressed in bacteria. J. Virol. 69:1093-1098.
32. Knox K, et al. 2011. No evidence of murine-like gammaretroviruses in CFS patients previously identified as XMRV-infected. Science 333:94 -97.
33. Krausslich HG, Facke M, Heuser AM, Konvalinka J, Zentgraf H. 1995. The spacer peptide between human immunodeficiency virus capsid and nucleocapsid proteins is essential for ordered assembly and viral infectivity. J. Virol. 69:3407-3419.
34. Kremer JR, Mastronarde DN, McIntosh JR. 1996. Computer visualization of three-dimensional image data using IMOD. J. Struct. Biol. 116: 71-76.
35. Kuznetsov YG, Ulbrich P, Haubova S, Ruml T, McPherson A. 2007. Atomic force microscopy investigation of Mason-Pfizer monkey virus and human immunodeficiency virus type 1 reassembled particles. Virology 360:434-446.
36. Li S, Hill CP, Sundquist WI, Finch JT. 2000. Image reconstructions of helical assemblies of the HIV-1 CA protein. Nature 407:409-413.
37. Liang C, Hu J, Whitney JB, Kleiman L, Wainberg MA. 2003. A structurally disordered region at theCterminus of capsid plays essential roles in multimerization and membrane binding of the Gag protein of human immunodeficiency virus type 1. J. Virol. 77:1772-1783.
38. Lombardi VC, et al. 2009. Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science 326: 585-589.
39. Ludtke SJ, Baldwin PR, Chiu W. 1999. EMAN: semiautomated software for high-resolution single-particle reconstructions. J. Struct. Biol. 128: 82-97.
40. Ma YM, Vogt VM. 2002. Rous sarcoma virus Gag proteinoligonucleotide interaction suggests a critical role for protein dimer formation in assembly. J. Virol. 76:5452-5462.
41. Ma YM, Vogt VM. 2004. Nucleic acid binding-induced Gag dimerization in the assembly of Rous sarcoma virus particles in vitro. J. Virol. 78:52- 60.
42. Macek P, et al. 2009. NMR structure of the N-terminal domain of capsid protein from the Mason-Pfizer monkey virus. J. Mol. Biol. 392: 100 -114.
43. Mortuza GB, et al. 2008. Structure of B-MLV capsid amino-terminal domain reveals key features of viral tropism, gag assembly and core formation. J. Mol. Biol. 376:1493-1508.
44. Mortuza GB, et al. 2004. High-resolution structure of a retroviral capsid hexameric amino-terminal domain. Nature 431:481- 485.
45. Paprotka T, et al. 2011. Recombinant origin of the retrovirus XMRV. Science 333:97-101.
46. Phillips JM, Murray PS, Murray D, Vogt VM. 2008. A molecular switch required for retrovirus assembly participates in the hexagonal immature lattice. EMBO J. 27:1411-1420.
47. Pornillos O, Ganser-Pornillos BK, Yeager M. 2011. Atomic-level modelling of the HIV capsid. Nature 469:424-427.
48. Raisch KP, et al. 2003. Molecular cloning, complete sequence, and biological characterization of a xenotropic murine leukemia virus constitutively released from the human B-lymphoblastoid cell line DG-75. Virology 308:83-91.
49. Robinson MJ, Erlwein O, McClure MO. 2011. Xenotropic murine leukaemia virus-related virus (XMRV) does not cause chronic fatigue. Trends Microbiol. 19:525-529.
50. Rumlova-Klikova M, Hunter E, Nermut MV, Pichova I, Ruml T. 2000. Analysis of Mason-Pfizer monkey virus Gag domains required for capsid assembly in bacteria: role of the N-terminal proline residue of CA in directing particle shape. J. Virol. 74:8452- 8459.
51. Satterfield BC, et al. 2011. Serologic and PCR testing of persons with chronic fatigue syndrome in the United States shows no association with xenotropic or polytropic murine leukemia virus-related viruses. Retrovirology 8:12.
52. Schutzer SE, Rounds MA, Natelson BH, Ecker DJ, Eshoo MW. 2011. Analysis of cerebrospinal fluid from chronic fatigue syndrome patients for multiple human ubiquitous viruses and xenotropic murine leukemiarelated virus. Ann. Neurol. 69:735-738.
53. Sfanos KS, et al. 2008. A molecular analysis of prokaryotic and viral DNA sequences in prostate tissue from patients with prostate cancer indicates the presence of multiple and diverse microorganisms. Prostate 68: 306-320.
54. Shin CH, et al. 2011. Absence of XMRV retrovirus and other murine leukemia virus-related viruses in patients with chronic fatigue syndrome. J. Virol. 85:7195-7202.
55. Still A, Huseby D, Barklis E. 2011. Analysis of the N-terminal region of the murine leukemia virus nucleocapsid protein. Virus Res. 155: 181-188.
56. Switzer WM, et al. 2010. Absence of evidence of xenotropic murine leukemia virus-related virus infection in persons with chronic fatigue syndrome and healthy controls in the United States. Retrovirology 7:57.
57. Ulbrich P, et al. 2006. Distinct roles for nucleic acid in in vitro assembly of purified Mason-Pfizer monkey virus CANC proteins. J. Virol. 80: 7089-7099.
58. Urisman A, et al. 2006. Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog. 2:e25.
59. van Heel M, Harauz G, Orlova EV, Schmidt R, Schatz M. 1996. A new generation of the IMAGIC image processing system. J. Struct. Biol. 116: 17-24.
60. Verhaegh GW, et al. 2011. Prevalence of human xenotropic murine leukemia virus-related gammaretrovirus (XMRV) in Dutch prostate cancer patients. Prostate 71:415- 420.
61. von Schwedler UK, et al. 1998. Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly. EMBO J. 17: 1555-1568.
62. von Schwedler UK, Stray KM, Garrus JE, Sundquist WI. 2003. Functional surfaces of the human immunodeficiency virus type 1 capsid protein. J. Virol. 77:5439 -5450.
63. Wang MQ, Goff SP. 2003. Defects in virion production caused by mutations affecting the C-terminal portion of the Moloney murine leukemia virus capsid protein. J. Virol. 77:3339-3344.
64. Wildova M, et al. 2008. The effect of point mutations within the N-terminal domain of Mason-Pfizer monkey virus capsid protein on virus core assembly and infectivity. Virology 380:157-163.
65. Wilk T, et al. 2001. Organization of immature human immunodeficiency virus type 1. J. Virol. 75:759-771.
66. Wright ER, et al. 2007. Electron cryotomography of immature HIV-1 virions reveals the structure of the CA and SP1 Gag shells. EMBO J. 26: 2218-2226.
67. Yeager M, Wilson-Kubalek EM, Weiner SG, Brown PO, Rein A. 1998. Supramolecular organization of immature and mature murine leukemia virus revealed by electron cryo-microscopy: implications for retroviral assembly mechanisms. Proc. Natl. Acad. Sci. U. S. A. 95: 7299-7304.
68. Yu F, et al. 2001. Characterization of Rous sarcoma virus Gag particles assembled in vitro. J. Virol. 75:2753-2764.